Authors
Latest:
What's your Web site doing for you?As more consumers hop onto the World Wide Web to search for information about healthcare, it's simply a must for dermatology practices to have Web sites.
Latest:
The right tool: Lesion type determines which laser, light device is best choiceHyperpigmented lesions come in many varieties. Etiologies vary from sun exposure to trauma to inflammation, and even idiopathic origins.
Latest:
Editorial Advisory Board Insights for Eczema Awareness Month: Helen Torok, MDHelen Torok, MD, shares her atopic dermatitis insights.
Latest:
Sulfasalazine, dapsone: Good alternative options for treatment of chronic urticariaPhiladelphia - In patients with chronic urticaria who do not respond to standard antihistamine treatment, the older drugs sulfasalazine and dapsone represent promising new treatment alternatives, Lisa A. Beck, M.D. said here at the 2006 meeting of the American College of Allergy, Asthma & Immunology (ACAAI).
Latest:
Effectively managing GIF in the psoriasis patientGIF typically manifests during the first six to 10 weeks of treatment, and affects existing plaques with or without the presence of new lesions.
Latest:
Etanercept presents as quick TxNational Report -- A study reported in a recent edition of the New England Journal of Medicine indicates people with moderate to severe plaque psoriasis treated with etanercept experienced significant clearing of skin lesions within the first two weeks of taking the medication.
Latest:
Tech breakthroughsDial-up modems, which opened the Internet to a vast audience and are still commonly found in medical offices, nominally create a 56k connection, although it is often closer to 44k and, depending on your line quality, 28k. With the prodigious amount of spam and viruses being circulated these days, it can often take 30 minutes or more just to download an e-mail, and if my colleagues have sent large picture files, it could take 45 minutes or more.
Latest:
Experimental therapy figures to save limbsCambridge, Mass. - An experimental therapy that makes use of fibroblast growth factor type 1 (FGF-1) encoded in naked plasmid DNA (NV1FGF) could save the limbs of patients afflicted with chronic wounds due to critical leg ischemia associated with peripheral arterial disease (PAD), according to Vincent Li, M.D., M.B.A.
Latest:
What's new in retirement planning?Defined benefit pension plans as well as cash balance plans are generating a lot of interest with medical practices, both large and small.
Latest:
Do You Have the Right Financial Adviser?Experts detail 5 tips to ask a financial advisor so they can best serve your interests.
Latest:
Four money-saving ideas can help you prepare for Tax Day 2010As a physician, do you realize that, between income, capital gains, Medicare, self-employment and other taxes, you spend 40 percent to 50 percent of your working hours laboring for the IRS and your state?
Latest:
New devices modify noninvasive skin tighteningApproximately 94 percent of patients treated with the multiple pass/low fluence algorithm showed visible skin tightening at the time of treatment.
Latest:
Resiliency: A Fundamental Success Factor in Any Financial PlanCheck out these 5 factors that can significantly impact a dermatologist’s financial plan and should therefore incorporate flexibility and resiliency to structure the plan for long-term success.
Latest:
Reducing no-showsStarting Oct. 1, 2007, the Centers for Medicare and Medicaid Services (CMS) officially endorsed the practice of physicians charging a fee to Medicare beneficiaries who fail to show up for appointments. If you charge Medicare patients a fee for missing appointments, however, you must charge the same fee to all who skip appointments, regardless of the payer.
Latest:
Surgeon shares rationale for lip on 12-year-oldThe circumstances around this case are quite unusual, but the bottom line is that I had been called upon to justify my position of doing liposuction and an abdominoplasty on a youngster.
Latest:
Living in a Litigious World Demands Defensive Asset ProtectionIn today's society, the lawsuit is seen as a way to "get rich quick" rather than as a method of creating justice.
Latest:
Reaching for a retinoid? Less may be moreWashington - Adapalene 0.1 percent gel is similar in efficacy against acne, with fewer side effects, than either tazarotene 0.1 percent or a regimen in which patients were switched from one retinoid to the other after six weeks.
Latest:
Pediatric dermatoses: Off-label biologic use carries risks, benefitsPsoriasis in adults is among the most-researched inflammatory skin diseases. Yet treatment options for moderate-to-severe atopic dermatitis and psoriasis in children represents a largely unmet medical need, according to an expert.
Latest:
Light intensifier: LED combo treats rosacea erythemaCombining LED therapy with laser or intense pulsed light can effectively treat rosacea and subsequent erythema, an expert says.
Latest:
Study finds HS associated with acne conglobataHidradenitis suppurativa has come to be associated with systemic inflammation as well as a growing list of comorbidities including acne conglobate.
Latest:
Polycystic ovary syndrome treatment requires holistic approachFor young women with polycystic ovary syndrome (PCOS), dermatologists must diagnose the underlying hormonal issues to best treat the related skin symptoms, explains Helen M. Torok, M.D., medical director, Trillium Creek Dermatology & Surgery, Medina, Ohio.
Latest:
Beautiful Minds?Leading sources suggest that cosmetic surgeons should carefully monitor the psychological condition and ambitions of existing and potential cosmetic patients despite a recent study finding that aesthetic procedures significantly improve a patient's quality of life.
Latest:
Key Takeaways For the Management of Plaque PsoriasisExperts in dermatology share closing thoughts on the management of plaque psoriasis.
Latest:
Long-term Safety and Tolerability Experience with TNF InhibitorsThe class of agents known as TNF inhibitors shares some common safety issues, but the safety profiles of specific agents vary due to differing characteristics and mechanisms. Comparing safety data of these drugs is, of course, complicated by differences in patient populations and experiences.
Latest:
Advancements in Psoriasis TreatmentsAlice Gottlieb, MD, PhD, put a spotlight on recent studies and the current psoriasis treatment armamentarium for dermatology clinicians to consider.
Latest:
Immune Pathogenesis of Psoriasis: Role of Biologic TherapiesThese are very exciting times for dermatology. Basic research is being applied to the development of new and more effective biologics to treat some of the most challenging conditions, psoriasis among them.
Latest:
Teledermatology helps patients help themselvesTeledermatology eases disease management for young acne patients.
Latest:
A new look at lipolysisBoston - Improvements on a non-invasive alternative to liposuction may revolutionize medical procedures in this area, according to a presentation at this year's International Master Course on Aging Skin.
Latest:
Melanoma overlooked, has higher mortality in African-American patientsWhile the incidence of melanoma is lower among African-Americans than it is among Caucasians, mortality due to melanoma is higher among the former. The reason, experts say, is because skin cancers in African-Americans appear on sites where they behave more aggressively, and there is a delay in diagnosis with this patient population.
Latest:
Build practice revenues through physician-dispensed product salesInventory management can be a challenge. First and foremost, it's critical to work within your cost analysis and projections to purchase the amount of product that you can physically store and sell.
